The Polypill in the Prevention of Cardiovascular Diseases Key Concepts, Current Status, Challenges, and Future Directions

CIRCULATION

LIPPINCOTT WILLIAMS & WILKINS

1. Astra-Zeneca
2. Boehringer Ingelheim
3. GlaxoSmithKline
4. Hoffman-Roche
5. Novartis
6. Sanofi-Aventis
7. Servier
8. Merck
9. Solvay
10. Cadila Pharma India
11. Wellcome Trust, UK
12. BMS
13. Cadila